Company Overview
Snapshot
Founded in October 2020 by Tomer Ben David and Uri Tal, Vortex Imaging operates with 11–50 employees. The company has raised $12 million across three funding rounds from five investors. In May 2026, Vortex Imaging announced a $12 million financing round, supported by existing and new investors, including 10D.
Business overview
Vortex Imaging is a Health Tech & Life Sciences company developing a novel medical imaging device designed to revolutionize the imaging world. The company's core technology is the world's first handheld, full volumetric (3D), operator-independent, low-cost, and safe ultrasound imaging modality. This technology is based on geophysics-inspired algorithms and computational software running with GPUs on the Cloud, serving the medical devices sector and healthcare providers.
Strategic signal
Vortex Imaging's recent $12 million financing round in May 2026, supported by investors like 10D, signals strong investor confidence in its computational ultrasound solutions. This capital infusion is poised to accelerate the development and market penetration of its handheld, 3D ultrasound technology, indicating a significant step towards disrupting the medical imaging market with accessible and high-quality diagnostic tools.
Log in to access full profile ›Company Intelligence Q&A
- What significant funding did Vortex Imaging recently secure?
- In May 2026, Vortex Imaging announced the closing of a $12 million financing round, supported by existing and new investors, including 10D.
- Who are the founders of Vortex Imaging?
- Vortex Imaging was co-founded by Tomer Ben David, who serves as CEO, and Uri Tal, who is Co-Founder, President & CTO.
- What is Vortex Imaging's primary technological innovation?
- Vortex Imaging is developing the world's first handheld, full volumetric (3D), operator-independent, low-cost, and safe ultrasound imaging modality, leveraging geophysics-inspired algorithms and cloud-based computational software.